Teva Pharmaceutical Industries Limited (TEVA)

TEVA · Health Care · Israel Israel

Teva Pharmaceutical Industries Limited (TEVA) is an Israeli company in the Health Care sector. The stock has its largest weight in SPFS (MSCI World Health Care), at 0.54%. Anyone who holds an ETF containing Teva Pharmaceutical Industries Limited also has an indirect stake in the company.

Data and Charts: Teva Pharmaceutical Industries Limited

Key Data for Teva Pharmaceutical Industries Limited

Held in17 ETFs
Highest weight0.54%
Indices8
SectorHealth Care
CountryIsrael
ISINIL0006290147

Data note 1

Teva Pharmaceutical Industries Limited Stock Price Chart

The Teva Pharmaceutical Industries Limited chart shows daily closing prices and is set to the current year by default. The stock is up 34.9% year to date and up 110.1% over twelve months. The last recorded close on October 30, 2026, was $42.09, at 100% of the 52-week range.

The chart shows the US listing in US dollars. On the home exchange the price can differ, since the currency and trading hours are different. For depositary receipts (ADRs), one receipt is not always one share.

Price series from our database since Sep 23, 2024, 529 daily values.

Data note 2

Teva Pharmaceutical Industries Limited Stock Performance

Teva Pharmaceutical Industries Limited stock performance
Year to date+34.9%1 year+110.1%
1 month+6.3%3 months+20.2%
Calendar year 2025+41.6%
52W

Data note 3

Measured in euros, Teva Pharmaceutical Industries Limited is up 41.8% year to date and up 117.2% over twelve months. The difference from the dollar figures above comes from the exchange rate alone. Each daily price is converted at the ECB euro reference rate for that day.

Data note 4

Alysly Data Analysis: Teva Pharmaceutical Industries Limited

What ETF Is Teva Pharmaceutical Industries Limited In?

Teva Pharmaceutical Industries Limited has above-average ETF coverage and is held by 17 of the 104 ETFs we track, which together follow 8 indices. That puts the stock in more ETFs than 77.7% of the 4,341 stocks we track.

Data note 5

What ETF is Teva Pharmaceutical Industries Limited in
ETFIndexWeightper €1,000 in the ETF
SPFSMSCI World Health Care0.54%€5.40
XDWHMSCI World Health Care0.54%€5.36
XDEVMSCI World Value0.24%€2.41
EXUS / EXU1MSCI World ex USA0.20%€1.96
XDEMMSCI World Momentum0.18%€1.77
WVALMSCI World Value0.16%€1.59
SWWDMSCI World0.06%€0.59
SPPWMSCI World0.06%€0.59
XDWD / XDWLMSCI World0.05%€0.53
EUNLMSCI World0.05%€0.50
WIMIMSCI World IMI0.05%€0.47
SPYYMSCI ACWI0.05%€0.47
SPYI / SPSAMSCI ACWI IMI0.04%€0.42
IUSQMSCI ACWI0.04%€0.40

Data note 6

The last column shows how much of €1,000 in one of these funds goes to Teva Pharmaceutical Industries Limited, based on each fund's latest holdings list.

US-listed ETFs holding Teva Pharmaceutical Industries Limited (weight per latest SEC filing): VXUS 0.09%. These funds are registered in the US; retail investors in the EU usually cannot buy them.

Teva Pharmaceutical Industries Limited Weight in iShares Core MSCI World (EUNL) Since 2019

Sep 30, 2019Oct 30, 2026

In iShares Core MSCI World (EUNL), Teva Pharmaceutical Industries Limited had a weight of 0.02% on Sep 30, 2019 and 0.05% on Oct 30, 2026. The fund tracks the MSCI World. Its share peaked at 0.05% on Sep 30, 2026. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.

Data note 7

What's Inside Your ETF Portfolio and the ETF overlap check show how much Teva Pharmaceutical Industries Limited overlaps with the rest of a portfolio.

What Teva Pharmaceutical Industries Limited Executives and Directors Traded Recently

Trades by executives and directors
DatePersonTypeSharesPrice
Sep 18, 2026Savage Brian Officer, Interim Chief Legal OfficerSell314$38.70
Sep 18, 2026Savage Brian Officer, Interim Chief Legal OfficerSell2,525$39.15
Sep 18, 2026Savage Brian Officer, Interim Chief Legal OfficerSell4,503$38.69
Sep 18, 2026MIGNONE ROBERTO DirectorSell367,600$39.06

The table shows open-market purchases and sales reported over the past 90 days. Directors, officers and shareholders owning more than ten percent must report such transactions within two trading days. Awards and option exercises are excluded.

“Plan” means the transaction follows a schedule set up in advance under Rule 10b5-1. Sales consistently outnumber purchases in these filings because a large part of executive pay is granted in shares. For comparison: over the period covered, executives and directors reported sales at 271 of 350 tracked companies and purchases at 32.

Data note 8

Stocks With ETF Exposure Similar to Teva Pharmaceutical Industries Limited

Stocks with ETF exposure similar to Teva Pharmaceutical Industries Limited
StockShared ETFsr
Teva Pharmaceutical Industries Limited––
CSL Limited16–
Wharf Real Estate Investment Company Limited14–
Fisher & Paykel Healthcare Corporation Limited14–
Woodside Energy Group15–
Magna International15–
Wilmar International Limited15–
CK Asset Holdings Limited14–
Sigma Healthcare Ltd14–

These stocks reach a portfolio through largely the same funds as Teva Pharmaceutical Industries Limited. “Shared ETFs” counts the funds that hold both.

Data note 9

Fundamental Analysis: Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited Key Financials

Revenue$17.3B
Net income$1.4B
Diluted EPS$1.21
Net margin8.2%
Gross margin51.8%
Return on equity17.8%
Equity ratio19.4%
Revenue growth+4.3%

Figures come from the SEC annual filing for the latest reported fiscal year (period end Dec 31, 2025).

Revenue and profit by fiscal year
Fiscal yearRevenueNet incomeMargin
FY ended Dec 202315.8-0.6-3.5%
FY ended Dec 202416.5-1.6-9.9%
FY ended Dec 202517.31.48.2%

Data note 10

Technical Analysis: Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited Risk Metrics

Max drawdown-43.7%
Annualized volatility43.6%

Data note 11

Below peak0.0%
Beta to S&P 5000.71
Correlation to S&P 5000.23

The close on Oct 30, 2026, was the highest since our series began on Sep 23, 2024. When the S&P 500 rose or fell 1%, Teva Pharmaceutical Industries Limited moved 0.71% on average in the same direction (past 252 trading days). The correlation of 0.23, however, shows only a moderate link to the broad market. Accordingly, moves in the S&P 500 explain only a small part of the daily price moves of Teva Pharmaceutical Industries Limited.

Data note 12

What Teva Pharmaceutical Industries Limited Correlates With

What Teva Pharmaceutical Industries Limited Correlates With
Instrumentr−1 … +1
Garmin Ltd.+0.47
GE Healthcare Technologies Inc.+0.42
ACH+0.42
HYPE+0.37
Sun Communities REIT Inc.+0.32
SiriusXM Holdings Inc.+0.32
MARSCOIN-0.37
Lennox International Inc.-0.35
Watsco Inc.-0.31

The strongest co-movers are listed at the top, the strongest inverse movers at the bottom. Low or negative correlations can help spread risk more broadly across a portfolio.

Data note 13

Related Content: Teva Pharmaceutical Industries Limited

Latest Investment Analysis: Stocks

Updated